In this issue:
Barriers to HCC surveillance
Toxicities of systemic therapies for advanced HCC
Ablative liver RT for unresected ICC
Impact of overweight and obesity on HCC risk in Asians
Prognostic factors for advanced HCC with elevated AFP treated with ramucirumab
Clinicopathological features, treatment, survival and prognosis of CHC
Adjuvant chemotherapy for perihilar cholangiocarcinoma
Predicting immune and inflammatory gene signatures from HCC histology
First-line microwave ablation vs. laparoscopic resection for 3-5cm HCC
Improved survival in viral but not nonviral HCC over last two decades
Please login below to download this issue (PDF)